Sequence Similarity Clusters for the Entities in PDB 1RZJ

Entity #1 | Chains: G
ENVELOPE GLYCOPROTEIN GP120 protein, length: 321 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 3 27701
95 % 11 15 4497 Flexibility: Medium
Max RMSD: 16.1, Avg RMSD: 5.5
PDBFlex
90 % 11 15 4538
70 % 66 189 130
50 % 66 189 158
40 % 66 189 168
30 % 66 192 182
Entity #2 | Chains: C
T-CELL SURFACE GLYCOPROTEIN CD4 protein, length: 185 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 16 39 850
95 % 17 45 812 Flexibility: Low
Max RMSD: 2.4, Avg RMSD: 1.2
PDBFlex
90 % 17 45 842
70 % 17 45 886
50 % 17 45 938
40 % 17 45 964
30 % 17 45 948
Entity #3 | Chains: L
ANTIBODY 17B, LIGHT CHAIN protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 13 22 1472
95 % 15 34 1095 Flexibility: Low
Max RMSD: 5.3, Avg RMSD: 1.2
PDBFlex
90 % 428 832 2
70 % 1358 2670 1
50 % 2785 5421 1
40 % 3179 6121 1
30 % 3880 7588 1
Entity #4 | Chains: H
ANTIBODY 17B, HEAVY CHAIN protein, length: 229 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 13 26 1187
95 % 13 26 1406 Flexibility: Low
Max RMSD: 3.9, Avg RMSD: 1.0
PDBFlex
90 % 13 26 1433
70 % 1351 2629 2
50 % 2786 5421 1
40 % 3180 6121 1
30 % 3881 7588 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
21 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
22 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
23 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
24 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
25 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
26 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
27 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
28 6BJZ 1 H 5c8 Fab Heavy chain 9606
29 6BJZ 2 L 5c8 Fab Light chain 9606
30 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
31 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
32 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
33 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
34 4XCF 1 L 4E10 Fab light chain 9606
35 4XCF 2 H 4E10 Fab heavy chain 9606
36 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
37 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
38 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
39 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
40 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
41 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
42 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
43 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
44 5X08 1 H Fab 4E10 Heavy chain 9606
45 5X08 2 L Fab 4E10 Light chain 9606
46 4XAW 1 L 4E10 Fab light chain 9606
47 4XAW 2 H 4E10 Fab heavy chain 9606
48 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
49 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
50 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
51 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
52 5UCB 1 H Fab Heavy Chain 9606
53 5UCB 2 L Fab Light Chain 9606
54 2VXV 1 H HUMAN IGG ABT-325 9606
55 2VXV 2 L HUMAN IGG ABT-325 9606
56 4GXV 1 H, I Antibody 1F1, heavy chain 9606
57 4GXV 2 L, M Antibody 1F1, light chain 9606
58 2VXT 1 H MURINE IGG 125-2H 10090
59 2VXT 3 L MURINE IGG 125-2H 10090
60 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
61 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
62 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
63 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
64 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
65 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
66 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
67 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
68 5W24 1 L 5C4 Fab Light Chain 10090
69 5W24 2 H 5C4 Fab Heavy Chain 10090
70 4HPY 1 H CH59 Fab heavy chain 9606
71 4HPY 2 L CH59 Fab light chain 9606
72 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
73 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
74 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
75 4JG1 1 L Fab light chain 9606
76 4JG1 2 H Fab heavy chain 9606
77 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
78 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
79 5VF2 1 A scFv 2D10 10090
80 5I8C 1 A VRC34.01 Fab heavy chain 9606
81 5I8C 2 B VRC34.01 Fab light chain 9606
82 4O5L 1 L Fab F045-092 light chain 9606
83 4O5L 2 H Fab F045-092 heavy chain 9606
84 5MYX 1 A, C Fab c#24 light chain 10090
85 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
86 3IFL 1 L 12A11 FAB antibody light chain 10090
87 3IFL 2 H 12A11 FAB antibody heavy chain 10090
88 5WK2 1 L M116 LIGHT CHAIN 9606
89 5WK2 2 H M116 HEAVY CHAIN FD 9606
90 3PP4 1 H GA101 Fab heavy chain 10090
91 3PP4 2 L GA101 Fab light chain 10090
92 3KDM 1 A, L Immunoglobulin light chain 9606
93 3KDM 2 B, H Immunoglobulin heavy chain 9606
94 5NIV 1 A Light chain of 5D3 Fab 10090
95 5NIV 2 B Heavy chain of 5D3 Fab 10090
96 5N4J 1 L LIGHT CHAIN 9606
97 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
98 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
99 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
100 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
101 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
102 5X4G 1 A 6H8 Fab heavy chain 10090
103 5X4G 2 B 6H8 Fab light chain 10090
104 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
105 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
106 4PTU 1 A Antibody pn132p2C05, light chain 9606
107 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
108 4TPR 1 L If kappa light chain 10090
109 4TPR 2 H Fab heavy chain 10090
110 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
111 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
112 3IFN 1 H 12A11 FAB antibody heavy chain 10090
113 3IFN 2 L 12A11 FAB antibody light chain 10090
114 5U3P 1 H DH511.4 Fab Heavy Chain 9606
115 5U3P 2 L DH511.4 Fab Light Chain 9606
116 6BLA 1 H AMM01 Fab Heavy chain 9606
117 6BLA 2 L AMM01 Fab Light chain 9606
118 4TOY 1 H 35O22 Fab Heavy chain 9606
119 4TOY 2 L 35O22 Fab Light chain 9606
120 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
121 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
122 3NPS 2 B S4 FAB HEAVY CHAIN 9606
123 3NPS 3 C S4 FAB LIGHT CHAIN 9606
124 5I4F 1 A scFv 2D10 10090
125 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
126 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
127 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
128 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
129 5WN9 1 H scFv 2D10 9606
130 4XC3 1 L 4E10 Fab light chain 9606
131 4XC3 2 H 4E10 Fab heavy chain 9606
132 4M5Y 1 H, I Fab 5J8 heavy chain 9606
133 4M5Y 2 L, M Fab 5J8 light chain 9606
134 4TQE 1 L If kappa light chain 10090
135 4TQE 2 H Fab heavy chain 10090
136 5YY4 1 A scFv 4B08 10090
137 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
138 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
139 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
140 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
141 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
142 5VSI 2 L CH1/Ckappa Fab light chain 9606
143 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
144 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
145 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
146 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
147 5JXA 1 H VRC03 Heavy chain 9606
148 5JXA 2 L VRC03 Light chain 9606
149 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
150 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
151 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
152 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
153 3NTC 1 L Fab light chain 10090
154 3NTC 2 H Fab heavy chain 10090
155 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
156 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
157 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
158 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
159 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
160 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
161 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
162 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
163 6BE3 1 H Fab (F598) Heavy Chain 9606
164 6BE3 2 L Fab (F598) Light Chain 9606
165 4NWU 1 H APE1551 Ab Fab heavy chain 9606
166 4NWU 2 L APE1551 Ab Fab light chain 9606
167 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
168 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
169 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
170 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
171 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
172 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
173 5EWI 1 H VRC38.01 Heavy Chain 9606
174 5EWI 2 L VRC38.01 Light Chain 9606
175 5E2W 1 L AT8 LIGHT CHAIN 10090
176 5E2W 2 H AT8 HEAVY CHAIN 10090
177 5MYK 1 A Fab c#17 light chain 10090
178 5MYK 2 B Fab c#17 heavy chain 10090
179 4NZR 1 H PGT135 heavy chain Fab 9606
180 4NZR 2 L PGT135 light chain Fab 9606
181 5MYO 1 A, C Fab c#6 light chain 10090
182 5MYO 2 B, D Fab c#6 heavy chain 10090
183 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
184 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
185 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
186 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
187 5UEL 1 H 354NC102 Fab Heavy Chain 9606
188 5UEL 2 L 354NC102 Fab Light Chain 9606
189 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
190 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
191 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
192 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
193 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
194 5E2V 1 L AT8 LIGHT CHAIN 10090
195 5E2V 2 H AT8 HEAVY CHAIN 10090
196 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
197 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
198 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
199 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
200 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
201 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
202 5JUE 1 L light chain of UIC2 Fab 10090
203 5JUE 2 H heavy chain of UIC2 Fab 10090
204 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
205 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
206 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
207 5JR1 1 H 10E8 heavy chain 9606
208 5JR1 2 L 10E8 mature light chain 9606
209 6CA7 1 L PCT64_13C light chain 9606
210 6CA7 2 H PCT64_13C heavy chain 9606
211 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
212 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
213 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
214 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
215 5OB5 2 H fAb Heavy chain 9606
216 5OB5 3 L fAb Light chain 9606
217 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
218 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
219 5I66 1 A 8B6 antibody, heavy chain 10090
220 5I66 2 B 8B6 antibody, light chain 10090
221 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
222 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
223 6BZY 1 H 22D11 Heavy Chain 10090
224 6BZY 2 L 22D11 Light Chain 10090
225 3QQ9 1 C, L 101F LIGHT CHAIN 10090
226 3QQ9 2 D, H 101F HEAVY CHAIN 10090
227 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
228 5TKK 3 L mouse antibody vFP5.01 light chain 10090
229 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
230 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
231 5W6C 1 H UCA Fab heavy chain 9606
232 5W6C 2 L UCA Fab light chain 9606
233 5I1K 1 L FAB LIGHT CHAIN 9606
234 5I1K 2 H FAB HEAVY CHAIN 9606
235 3OZ9 1 L Fab NC-1 kappa light chain 10090
236 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
237 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
238 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
239 5V7U 1 L CBTAU-22.1 Fab light chain 9606
240 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
241 5UEA 1 A, H Fab Heavy Chain 9606
242 5UEA 3 B, L Fab Light Chain 9606
243 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
244 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
245 3G5Y 1 A 175 light chain 10090
246 3G5Y 2 B 175 heavy chain 10090
247 5NMV 1 L Fab light chain 10088
248 5NMV 2 H Fab heavy chain 10088
249 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
250 4N8C 2 L, M Light chain of monoclonal antibody 10090
251 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
252 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
253 4HGW 1 A Antibody Fab fragment, light chain 10090
254 4HGW 2 B Antibody Fab fragment, heavy chain 10090
255 1NLB 1 L antibody 19D9D6 light chain 10090
256 1NLB 2 H antibody 19D9D6 heavy chain 10090
257 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
258 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
259 3VFG 1 L 3F8 Light Chain 10090
260 3VFG 2 H 3F8 Heavy Chain 10090
261 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
262 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
263 3QRG 1 L Fab light chain 9606
264 3QRG 2 H Fab heavy chain Fd fragment 9606
265 5M6A 1 A, B, C, D Bence-Jones light chain 9606
266 4LLY 2 B, D light chain Clambda 9606
267 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
268 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
269 5EZI 1 H Fab c12 heavy chain 9606
270 5EZI 2 L Fab c12 Light chain 9606
271 4K23 1 H anti-uPAR antibody, heavy chain 10090
272 4K23 2 L anti-uPAR antibody, light chain 10090
273 3NCJ 1 L Fab15 Mut8 light chain 9606
274 3NCJ 2 H Fab15 Mut8 heavy chain 9606
275 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
276 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
277 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
278 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
279 5W05 1 L M59 FAB LIGHT CHAIN 10090
280 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
281 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
282 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
283 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
284 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
285 4M61 1 A, C Fab A52 light chain 10090
286 4M61 2 B, D Fab A52 heavy chain 10090
287 5YE3 1 B 2A7D9 VH CH1 chain 10090
288 5YE3 2 A 2A7D9 L chain 10090
289 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
290 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
291 1UM5 1 L Antibody 21H3 L chain 10090
292 1UM5 2 H Antibody 21H3 H chain 10090
293 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
294 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
295 4NWT 1 L APE1531 Ab Fab light chain 9606
296 4NWT 2 H APE1531 Ab Fab heavy chain 9606
297 3WHX 1 A mAb Fab H fragment 10090
298 3WHX 2 B mAb Fab L fragment 10090
299 3NA9 1 L Fab15 light chain 9606
300 3NA9 2 H Fab15 heavy chain 9606
301 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
302 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
303 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
304 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
305 4LRI 1 A, B MSL-109 Light Chain 9606
306 4LRI 2 C, P MSL-109 Heavy Chain 9606
307 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
308 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
309 4JN2 1 A, L anti dabigatran Fab 10090
310 4JN2 2 B, H anti dabigatran Fab 10090
311 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
312 4XBE 2 H 4E10 Fab heavy chain 9606
313 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
314 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
315 6BE2 1 H Fab (F598) Heavy Chain 9606
316 6BE2 2 L Fab (F598) Light Chain 9606
317 4JFZ 1 L Fab light chain 9606
318 4JFZ 2 H Fab heavy chain 9606
319 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
320 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
321 3WIF 1 A mAb Fab H fragment 10090
322 3WIF 2 B mAb Fab L fragment 10090
323 5U6A 1 A Light Chain 9606
324 5U6A 2 B Heavy Chain 9606
325 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
326 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
327 3MBX 1 L X836 LIGHT CHAIN 10090
328 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
329 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
330 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
331 6APC 1 H Epididymis luminal protein 214 9606
332 6APC 2 L IGL@ protein 9606
333 4HHA 1 A Fab KE5 Fab fragment KE5 9606
334 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
335 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
336 4RGO 2 H 14G8 heavy chain Fab 10090
337 4RGO 3 L 14G8 light chain Fab 10090
338 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
339 5GRY 1 A, G diabody 9606
340 5UEK 2 H Fab 12E Heavy Chain 9606
341 5UEK 3 L Fab 12E Light Chain 9606
342 3NAA 1 L Fab15 Mut5 light chain 9606
343 3NAA 2 H Fab15 Mut5 heavy chain 9606
344 1Q0X 1 L Fab 9B1, light chain 10090
345 1Q0X 2 H Fab 9B1, heavy chain 10090
346 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
347 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
348 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
349 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
350 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
351 5IK3 2 B, D 1E03 Fab fragment light chain 9606
352 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
353 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
354 5XLI 1 a, b FabL 10090
355 5XLI 2 c, d FabH 10090
356 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
357 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
358 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
359 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
360 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
361 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
362 4WUK 1 H CH65 heavy chain 9606
363 4WUK 2 L CH65 light chain 9606
364 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
365 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
366 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
367 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
368 5JOP 1 D, L Fab 14.22 light chain 10090
369 5JOP 2 E, H Fab14.22 heavy chain 10090
370 4HPO 1 H CH58 Fab heavy chain 9606
371 4HPO 2 L CH58 Fab light chain 9606
372 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
373 5UKN 2 L DH522UCA Fab fragment light chain 9544
374 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
375 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
376 5IT2 1 H heavy chain 9606
377 5IT2 2 L light chain 9606
378 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
379 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
380 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
381 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
382 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
383 5MO3 3 L Fab of monoclonal antibody, light chain 10090
384 5GZ0 1 A, C FM329 light chain 1383439
385 5GZ0 2 B, D FM329 heavy chain 1383439
386 6DW2 1 A 6078 Fab light chain 9606
387 6DW2 2 B 6078 Fab heavy chain 9606
388 6BQB 1 L MGG4 Fab light chain 9606
389 6BQB 2 H MGG4 Fab heavy chain 9606
390 4PUB 1 H DX-2930 HEAVY CHAIN 9606
391 4PUB 2 L DX-2930 LIGHT CHAIN 9606
392 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
393 6B14 2 L Light chain of Fab BL3-6S97N 10090
394 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
395 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
396 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
397 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
398 5GS3 1 A, H diabody protein 9606
399 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
400 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
401 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
402 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
403 5VKD 2 H Fab Heavy Chain 9606
404 5VKD 3 L Fab light chain 9606
405 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
406 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
407 5XHG 1 A, C polypeptide(L) 10090
408 5XHG 2 B, D polypeptide(H) 10090
409 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
410 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
411 3UYR 1 H antibody Fab heavy chain 10090
412 3UYR 2 L antibody Fab light chain 10090
413 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
414 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
415 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
416 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
417 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
418 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
419 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
420 3OAZ 2 K, L Fab 2G12, light chain 9606
421 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
422 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
423 1ZAN 1 L Fab AD11 Light Chain 10116
424 1ZAN 2 H Fab AD11 Heavy Chain 10116
425 6CJK 1 A, C Immunoglobulin Fab light chain 9986
426 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
427 4N0Y 1 H IGH526 Heavy Chain 9606
428 4N0Y 2 L IGH526 Light Chain 9606
429 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
430 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
431 5MTH 1 A, H antibody Fab heavy chain 10090
432 5MTH 2 B, L antibody Fab light chain 10090
433 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
434 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
435 1RZF 1 L Fab E51 light chain 9606
436 1RZF 2 H Fab E51 heavy chain 9606
437 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
438 4KTE 2 L GE148 Light Chain Fab 9544
439 5I8O 1 H HMM5 antibody heavy chain 9606
440 5I8O 2 L HMM5 antibody light chain 9606
441 4JG0 1 L Fab light chain 9606
442 4JG0 2 H Fab heavy chain 9606
443 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
444 4YGV 2 B, L aDabi-Fab2a light chain 9606
445 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
446 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
447 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
448 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
449 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
450 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
451 3EO0 1 A, C GC-1008 Fab Light Chain 10090
452 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
453 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
454 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
455 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
456 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
457 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
458 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
459 4FQI 3 H antibody CR9114 heavy chain Fab 9606
460 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
461 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
462 4JHA 2 L D25 light chain 9606
463 6B9Z 1 A Trastuzumab Fab light chain 10090
464 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
465 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
466 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
467 4PTT 1 A Antibody pn132p2C05, light chain 9606
468 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
469 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
470 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
471 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
472 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
473 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
474 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
475 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
476 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
477 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
478 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
479 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
480 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
481 4DGV 1 H HCV1 Heavy Chain Fab 9606
482 4DGV 2 L HCV1 Light Chain 9606
483 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
484 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
485 5TH2 1 A, C cetuximab Fab, light chain 10090
486 5TH2 2 B, D cetuximab Fab, heavy chain 10090
487 5I8K 1 L HHH1 Fab Light chain 9606
488 5I8K 2 H HHH1 Fab Heavy chain 9606
489 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
490 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
491 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
492 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
493 1YNL 1 L Ig gamma light chain 10090
494 1YNL 2 H Ig gamma heavy chain 10090
495 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
496 5EPM 2 B, F Antibody Fab fragment light chain 10090
497 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
498 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
499 3UMT 1 A scFv heavy chain and light chain 10090
500 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
501 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
502 4NUJ 1 A PGT152 light chain 9606
503 4NUJ 2 B PGT152 heavy chain 9606
504 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
505 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
506 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
507 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
508 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
509 3U2S 2 B, L PG9 light chain 9606
510 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
511 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
512 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
513 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
514 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
515 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
516 4NUG 1 L PGT151 light chain 9606
517 4NUG 2 H PGT151 heavy chain 9606
518 3IU4 1 H chP3 Fab heavy chain 10090
519 3IU4 2 L chP3 Fab light chain 10090
520 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
521 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
522 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
523 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
524 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
525 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
526 1P7K 1 A, L antibody light chain FAB 10090
527 1P7K 2 B, H antibody heavy chain FAB 10090
528 3RVV 2 C 4C1 - light chain 10090
529 3RVV 3 D 4C1 - heavy chain 10090
530 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
531 3P0Y 2 H Fab DL11 heavy chain 9606
532 3P0Y 3 L Fab DL11 light chain 9606
533 4NPY 1 A, L germline PGT121 light chain Fab 9606
534 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
535 6ANA 2 H LL2 Fab Heavy Chain 10090
536 6ANA 3 L LL2 Fab Light Chain 10090
537 5IBU 1 B, L 6652 Light Chain 9606
538 5IBU 2 G, H 6652 Heavy Chain 9606
539 5VPL 2 C 4C1 - LIGHT CHAIN 10090
540 5VPL 3 D 4C1 - HEAVY CHAIN 10090
541 6AOD 1 A FXIa Antibody FAB Light Chain 9606
542 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
543 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
544 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
545 2YPV 2 H FAB 12C1 10090
546 2YPV 3 L FAB 12C1 10090
547 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
548 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
549 4JY5 1 L PGT122 light chain Fab 9606
550 4JY5 2 H PGT122 heavy chain Fab 9606
551 6ELE 1 A, H fAB heavy chain 9606
552 6ELE 2 B, L fAB light chain 9606
553 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
554 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
555 6B5R 1 H CIS42 Fab Heavy chain 9606
556 6B5R 2 L CIS42 Fab Light chain 9606
557 3NAC 1 L Fab15 Mut7 light chain 9606
558 3NAC 2 H Fab15 Mut7 heavy chain 9606
559 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
560 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
561 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
562 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
563 1Q72 1 L Fab M82G2, Light chain 10090
564 1Q72 2 H Fab M82G2, Heavy chain 10090
565 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
566 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
567 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
568 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
569 4YHO 1 H aDabi-Fab3 heavy chain 9606
570 4YHO 2 L aDabi-Fab3 light chain 9606
571 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
572 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
573 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
574 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
575 4DGY 1 H HCV1 Heavy Chain Fab 9606
576 4DGY 2 L HCV1 Light Chain 9606
577 5EN2 1 A GD01 heavy chain 10090
578 5EN2 2 B GD01 light chain 10090
579 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
580 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
581 3MXW 2 L 5E1 light chain 9606
582 3MXW 3 H 5E1 heavy chain 9606
583 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
584 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
585 3EO9 1 L Efalizumab Fab fragment, light chain 9606
586 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
587 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
588 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
589 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
590 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
591 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
592 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
593 5WUV 1 L light chain 9606
594 5WUV 2 H heavy chain 9606
595 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
596 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
597 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
598 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
599 4JM4 1 H PGT 135 Heavy Chain Fab 9606
600 4JM4 2 L PGT 135 Light Chain Fab 9606
601 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
602 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
603 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
604 5YE4 2 B, D 1A9D7 L chain 10090
605 6B0G 1 C 1245 Antibody, Light Chain 9606
606 6B0G 2 D 1245 Antibody, Heavy Chain 9606
607 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
608 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
609 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
610 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
611 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
612 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
613 6D0X 1 A 2140 Antibody, heavy chain 9606
614 6D0X 2 B 1210 Antibody, light chain 9606
615 6BE4 1 H Fab (F598) Heavy Chain 9606
616 6BE4 2 L Fab(F598) Light Chain 9606
617 5TPP 1 L DH270.5 Fab heavy chain 9606
618 5TPP 2 H DH270.5 Fab light chain 9606
619 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
620 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
621 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
622 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
623 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
624 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
625 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
626 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
627 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
628 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
629 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
630 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
631 5TL5 1 L M2177 LIGHT CHAIN 10090
632 5TL5 2 H M2177 HEAVY CHAIN 10090
633 2FX7 1 L Fab 4E10 Light Chain 9606
634 2FX7 2 H Fab 4E10 Heavy Chain 9606
635 5Y9K 1 L belimumab light chain 9606
636 5Y9K 2 H belimumab heavy chain 9606
637 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
638 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
639 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
640 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
641 3WFH 1 A mAb Fab H fragment 10090
642 3WFH 2 B mAb Fab L fragment 10090
643 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
644 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
645 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
646 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
647 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
648 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
649 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
650 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
651 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
652 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
653 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
654 5HI4 3 D, L CAT-2000 FAB light chain 9606
655 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
656 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
657 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
658 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
659 3RVW 2 C 4C1 - light chain 10090
660 3RVW 3 D 4C1 - heavy chain 10090
661 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
662 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
663 5XKU 2 B HNIgGA6 light chain 9606
664 5XKU 3 C HNIgGA6 heavy chain 9606
665 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
666 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
667 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
668 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
669 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
670 5HI5 3 D, L CAT-2000 light chain 9606
671 5JO5 1 A, C, E, H 10E8 gHV 9606
672 5JO5 2 B, D, F, L 10E8 gLV 9606
673 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
674 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
675 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
676 5CCK 2 L Antibody 3BC315 Fab light chain 9606
677 5I76 1 A, C FM318_light_chain 1383439
678 5I76 2 B, D FM318_heavy_cahin 1383439
679 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
680 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
681 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
682 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
683 5I18 1 L FAB LIGHT CHAIN 9606
684 5I18 2 H FAB HEAVY CHAIN 9606
685 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
686 4JN1 2 L anti-dabigatran Fab1, light chain 10090
687 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
688 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
689 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
690 4G5Z 2 L canakinumab antibody fragment light chain 9606
691 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
692 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
693 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
694 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
695 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
696 2OK0 2 L Fab ED10 light chain 10090
697 2OK0 3 H Fab ED10 heavy chain 10090
698 3SOB 1 L antibody light chain 9606
699 3SOB 3 H antibody heavy chain 9606
700 6B5M 1 H CIS43 Fab Heavy chain 9606
701 6B5M 2 L CIS43 Fab Light chain 9606
702 5AWN 1 H Heavy chain of 3BC176 Fab 9606
703 5AWN 2 L Light chain of 3BC176 Fab 9606
704 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
705 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
706 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
707 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
708 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
709 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
710 5DR5 2 L AbD09097 Fab light chain 9606
711 2IH3 1 A FAB Heavy Chain 10090
712 2IH3 2 B FAB Light Chain 10090
713 4KQ3 1 L CNTO3186 light chain Fab 9606
714 4KQ3 2 H CNTO3186 heavy chain Fab 9606
715 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
716 6AQ7 3 L POM6 FAB light CHAIN 10090
717 4JFX 1 A, L Fab light chain 9606
718 4JFX 2 B, H Fab heavy chain 9606
719 3SGE 1 I, L Light Chain 10090
720 3SGE 2 H, J Heavy Chain 10090
721 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
722 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
723 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
724 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
725 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
726 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
727 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
728 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
729 5FHB 1 H Antibody 100 Fab heavy chain 9606
730 5FHB 2 L Antibody 100 Fab light chain 9606
731 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
732 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
733 1JGU 1 L Antibody Light Chain 10090
734 1JGU 2 H Antibody Heavy Chain 10090
735 4I77 1 H Lebrikizumab heavy chain Fab 9606
736 4I77 2 L Lebrikizumab light chain Fab 9606
737 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
738 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
739 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
740 4O4Y 2 H 2095-2 heavy chain 9986
741 5OBF 1 H fAb Heavy chain 10090
742 5OBF 2 L fAb Light chain 10090
743 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
744 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
745 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
746 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
747 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
748 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
749 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
750 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
751 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
752 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
753 5MHE 1 L Fab-fragment 10090
754 5MHE 2 H Fab-fragment 10090
755 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
756 4GLR 3 I, K anti-ptau light chain light chain 9031
757 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
758 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
759 4HJG 1 A Trastuzumab light chain 9606
760 4HJG 2 B Trastuzumab heavy chain 9606
761 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
762 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
763 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
764 5I30 1 L Fab PL-2 light chain 10090
765 5I30 2 H Fab PL-2 heavy chain 10090
766 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
767 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
768 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
769 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
770 3FN0 1 L Fab Z13e1 light chain 9606
771 3FN0 2 H Fab Z13e1 heavy chain 9606
772 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
773 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
774 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
775 4YHI 2 B, L aDabi-Fab2a light chain 9606
776 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
777 5NYX 2 L, N, P